Prostate Cancer | Tumor

CURE’s prostate cancer page is an extensive resource of cancer information featuring the latest prostate cancer news, expert oncologist insights on the latest cancer treatments, oncology research, advocacy efforts, and medical data on prostate cancer.

Genetic Mutations in Men

February 20th 2020

Laws and Legislation Protecting Those with a Genetic Predisposition

February 20th 2020

Talking About Direct-To-Consumer Genetic Testing

February 20th 2020

Equal Access Health Care May Improve Survival Outcomes Among Men with Prostate Cancer

January 28th 2020

A study of the Veterans Affairs health system found that, despite trends suggesting otherwise, African American men with prostate cancer had similar survival outcomes, compared with non-Hispanic White men.

Vegetable Consumption Does Not Decrease Prostate Cancer Progression

January 19th 2020

Researchers found that men with prostate cancer who consumed a diet high in vegetable did not experience clinical benefit; however, overall health benefits were seen.

Price Transparency May Not Aid Patients in Preparing for Financial Toxicity

January 17th 2020

How providers communicate medical bills to payers and patients, mandated by the US Centers for Medicare & Medicaid Services, still did not help patients and health care professionals in understanding differences in cost.

Family History, Genetic Risk Score Combined Improves Prostate Cancer Screening

January 5th 2020

Researchers found that combining family history and genetic risk scores to determine inherited risk for prostate cancer could personalize screening strategies for men.

Dietary Supplement May Derive Benefit in Prostate Cancer, Larger Studies are Warranted

January 3rd 2020

A modified citrus pectin, naturally found in the peel of citrus fruits, showed continued benefit among men with prostate cancer.

What You Need to Know About the FDA's Approval of Xtandi in Prostate Cancer

December 22nd 2019

Men with metastatic castration-sensitive prostate cancer will now have a fourth treatment option to consider.

FDA Approves Xtandi to Treat Metastatic Castration-Sensitive Prostate Cancer

December 17th 2019

The Food and Drug Administration approved Xtandi for the treatment of patients with metastatic castration-sensitive prostate cancer.

Exploring the Link Between Infertility and Prostate Cancer

December 6th 2019

New research suggests men with infertility could face a 30% to 60% higher risk of prostate cancer.

Exploring the Future of Prostate Cancer with City of Hope

November 27th 2019

Although one in nine men will receive a prostate cancer diagnosis in his lifetime, cutting-edge research has allowed more men to live longer or even be cured.

There's Always Hope in Prostate Cancer

November 21st 2019

On this week’s episode of the CURE Talks Cancer podcast, we talk with Grammy-winning songwriter and vocal producer Kuk Harrell about what it’s like to be “on the other side” of his prostate cancer diagnosis, and how he’s using his platform to shine a light on the disease.

Every Day Is an Awakening

November 13th 2019

Following a prostate cancer diagnosis, one survivor ditches the ‘macho man’ attitude for a lighter approach to life.

Prostate Cancer Loves Couch Potatoes

November 7th 2019

In order to turn your prostate cancer into a couch potato and keep it from spreading, your best chance is not to be one yourself.

The Role of Germline Testing in Prostate Cancer

October 30th 2019

During the 2019 Prostate Cancer Consensus Conference, one expert discussed three clinical trials and the future of genetic testing in patients with the disease.

New Issue Alert: Genitourinary Cancers

October 23rd 2019

We've got a sneak peek at what’s inside CURE®'s 2019 Genitourinary Cancers special issue.

New Genetic Testing Recommendations Could Improve Early Detection in Prostate Cancer

October 20th 2019

Recent changes to the National Comprehensive Cancer Network (NCCN) guidelines around prostate cancer have updated the indications for genetic testing and have opened up a broader discussion on how it can be used to improve prostate cancer detection and treatment, according to Dr. James Mohler.

Polishing the Gold Standard in Prostate Cancer

October 18th 2019

Active surveillance has become the treatment of choice for low-risk prostate cancer, but new tools are needed to make it more precise.

Growing Knowledge Will Help Refine Decisions About Who Should Participate in Active Surveillance of Prostate Cancer

October 18th 2019

In the medical community, we know that, at a population level, active surveillance is better for certain men with prostate cancer, so we believe the benefit weighs in their favor. We would like to offer men more certainty that surveillance can work for them and hope that, in the next few years, research will bring that to pass.

Obesity Linked With Higher Distress in Breast and Prostate Cancers

October 7th 2019

Obese patients being treated for breast or prostate cancer showed higher levels of mental and physical distress than nonobese patients with these diseases, but the pattern did not hold true in those with colorectal cancer, according to a study.

Radiation After Surgery May Not Be Necessary Among Men With Prostate Cancer

October 6th 2019

A recent study found no different in disease recurrence among men with prostate cancer when they were given radiation after surgery or not.

Targeting DNA Repair Pathways With Lynparza May Delay Prostate Cancer Progression

October 3rd 2019

Phase 3 trial findings showed that treatment with Lynparza delayed disease progression by about four months compared with newer hormonal agents in pre-treated patients with metastatic castration-resistant prostate cancer and faulty DNA repair genes.

Erleada May Extend Subsequent Progression in Men With Castration-Resistant Prostate Cancer

September 28th 2019

Morever, the next-generation androgen receptor improved overall survival, compared with placebo, in patients with nonmetastatic castration-resistant prostate cancer, according to updated findings of the phase 3 SPARTAN trial.

CURE's Clinical Trial Corner: September 2019

September 25th 2019

Here is a list of the recent trial initiations that occurred within the cancer space in September.

Prostate Cancer Awareness Month: What You Need to Know

September 23rd 2019

For Prostate Cancer Awareness Month, here’s a round-up of the latest news and updates in this disease space.

What Men Should Know About the FDA's Approval of Erleada

September 21st 2019

Men with castration-sensitive prostate cancer now have an option for when treatment with androgen deprivation therapy alone is not enough.

FDA Approves Erleada for Patients With Metastatic Castration-Sensitive Prostate Cancer

September 18th 2019

A phase 3 trial showed a 33% reduction in the risk of death when patients were treated with Erleada compared with placebo.

Prostate Awareness May Save Your Life

September 3rd 2019

I encourage men to be more knowledgeable of their family history and to potentially begin testing for prostate cancer earlier if you have a family history of the disease.

CURE's Cancer Clinical Trial Corner: August 2019

August 27th 2019

Here is a list of the recent trial initiations that occurred within the cancer space in August.